A previous study showed that tumor-infiltrating mast cells colocalize with regulatory T cells, coincide with local reduction of MHC-I and CD8 T cells, and is associated with anti-PD-1 resistance, which can be reversed by c-kit inhibitor treatment. The gene discussed is CD8A; the disease is neoplasm.